<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05098301</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0562</org_study_id>
    <nct_id>NCT05098301</nct_id>
  </id_info>
  <brief_title>Data Therapy Collection to Evaluate Performances of an Automated Insulin Titration Algorithm Compared to Standard Method of Titration</brief_title>
  <acronym>GLUCAL3</acronym>
  <official_title>Data Therapy Collection to Evaluate Performances of an Automated Insulin Titration Algorithm Compared to Standard Method of Titration</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A data collection of blood glucose values, insulin, meal composition will be performed for a&#xD;
      period of two months, to evaluate the performances of an automated insulin titration&#xD;
      algorithm&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 30, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>evaluate the performances of an insulin titration algorithm</measure>
    <time_frame>day 1</time_frame>
    <description>to evaluate the performances of an insulin titration algorithm to calculate insulin therapy parameters at the same precision of an expert practitioner</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>measure time-in-range evolution adjustment of insulin therapy parameters</measure>
    <time_frame>day 1</time_frame>
    <description>to measure time-in-range evolution before and after adjustment of insulin therapy parameters by practitioner</description>
  </secondary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Diabetes</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Type 1 diabetic patients&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Person with Type 1 diabetes&#xD;
&#xD;
          -  Treated by basal-bolus therapy with MDI or pump&#xD;
&#xD;
          -  Patient with social security or beneficiary of medical coverage&#xD;
&#xD;
          -  Patient using functional insulin therapy or starting and education course&#xD;
&#xD;
          -  Patient able to read and understand the procedure, and able to express consent for&#xD;
             study protocol&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Patient abusing substances&#xD;
&#xD;
          -  Patient deprived of liberty by judicial or administrative decision, person subject to&#xD;
             a legal protection measure, patient having a psychological condition making him unable&#xD;
             to follow and understand study protocol&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric RENARD, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eric RENARD, MD, PhD</last_name>
    <phone>467338382</phone>
    <phone_ext>33</phone_ext>
    <email>e-renard@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Eric RENARD, MD, phD</last_name>
      <email>e-renard@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 18, 2021</study_first_submitted>
  <study_first_submitted_qc>October 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 28, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Functional insulin therapy</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

